Match!

Intratumor and circulating clonal heterogeneity shape the basis of precision breast cancer therapy

Published on Jan 1, 2017in Future Oncology2.28
· DOI :10.2217/fon-2016-0307
Demosthenes E Ziogas5
Estimated H-index: 5
,
John Spiliotis15
Estimated H-index: 15
+ 2 AuthorsDimitrios H Roukos62
Estimated H-index: 62
Abstract
  • References (17)
  • Citations (1)
References17
Newest
#1Julia A. Beaver (CDER: Center for Drug Evaluation and Research)H-Index: 8
#2Laleh Amiri-Kordestani (CDER: Center for Drug Evaluation and Research)H-Index: 8
Last.P. Cortazar (CDER: Center for Drug Evaluation and Research)H-Index: 8
view all 21 authors...
#1Yong WangH-Index: 8
#2Jill Waters (University of Texas MD Anderson Cancer Center)H-Index: 4
Last.Nicholas NavinH-Index: 27
view all 16 authors...
#1A. Goldhirsch (IEO: European Institute of Oncology)H-Index: 99
#2RichardD. Gelber (Harvard University)H-Index: 120
Last.José Baselga (MSK: Memorial Sloan Kettering Cancer Center)H-Index: 137
view all 25 authors...
View next paperGenetic and Functional Drivers of Diffuse Large B Cell Lymphoma